India  

U.S. FDA authorizes second vaccine

Video Credit: Reuters - Politics - Duration: 00:45s - Published
U.S. FDA authorizes second vaccine

U.S. FDA authorizes second vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost.

Gavino Garay reports.

The U.S. Food and Drug Administration gave Moderna the green light on Friday night to provide doses of its coronavirus vaccine to millions of Americans for inoculation.

Moderna's vaccine became the second to the receive emergency use authorization, or EUA -- welcome news to a nation with a staggering COVID-19 death toll of over 311,000 lives lost.

The FDA announced the authorization the day after the agency's panel of outside experts endorsed its use.

The authorization follows an EUA granted for a similar vaccine from Pfizer and German partner BioNTech that has been put into the arms of thousands of U.S. healthcare workers this week in a massive nationwide rollout.




You Might Like


💡 newsR Knowledge: Other News Mentions

Food and Drug Administration Food and Drug Administration Agency of the US Department of Health and Human Services

Novavax CEO: 'Burden's on us' to convince FDA on UK data [Video]

Novavax CEO: 'Burden's on us' to convince FDA on UK data

Novavax is on the cusp of getting approval for its Covid-19 vaccine. CEO Stanley Erck says proving to the FDA that the UK trial data is comparable could get the vaccine into the US faster.

Credit: Bleacher Report AOL    Duration: 02:54Published
US Begins Distributing a Third COVID-19 Vaccine [Video]

US Begins Distributing a Third COVID-19 Vaccine

Johnson & Johnson's coronavirus vaccine was authorized for emergency use by the Food and Drug Administration (FDA) on Feb. 27

Credit: Cover Video STUDIO    Duration: 01:18Published
J&J's next vaccine shipment hinges on regulators [Video]

J&J's next vaccine shipment hinges on regulators

Johnson & Johnson will ship nearly 4 million doses of its newly authorized single-dose COVID-19 vaccine around the United States this week, but a top executive said on Monday that the next round of deliveries is contingent on regulatory approvals at a new plant. Gloria Tso reports.

Credit: Reuters - Politics    Duration: 01:24Published
FDA approves third Covid-19 vaccine from Johnson & Johnson [Video]

FDA approves third Covid-19 vaccine from Johnson & Johnson

The US just added another powerful tool against Covid-19 to its inventory: a third vaccine. Johnson & Johnson is shipping nearly 4 million doses around the country today. CNN’s Pete Muntean is outside a UPS facility in Kentucky.

Credit: Bleacher Report AOL    Duration: 08:13Published
Fauci urges Americans to get any of 3 vaccines [Video]

Fauci urges Americans to get any of 3 vaccines

[NFA] Dr. Anthony Fauci, the top U.S. infectious disease official, on Sunday urged Americans to take any of the three approved COVID-19 vaccines available to them, including the newly-authorized single-shot vaccine from Johnson & Johnson. Lisa Bernhard produced this report.

Credit: Reuters - Politics    Duration: 01:41Published

Moderna Moderna American biotechnology company

Dolly Parton Gets First Dose of Moderna COVID Vaccine, Busts out New Song

Dolly Parton's employing her enormous talent and wealth to encourage folks to follow in her awesome footsteps, and get the COVID-19 vaccine. The beloved "9 to 5"..
TMZ.com
J&J files for U.S. COVID-19 vaccine authorization [Video]

J&J files for U.S. COVID-19 vaccine authorization

Johnson & Johnson said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it will apply to European authorities in coming weeks. Gloria Tso reports.

Credit: Reuters - Politics    Duration: 01:34Published
Johnson & Johnson's single-shot vaccine proves effective in trial, but less so than Moderna, Pfizer [Video]

Johnson & Johnson's single-shot vaccine proves effective in trial, but less so than Moderna, Pfizer

Johnson & Johnson says its single-shot COVID-19 vaccine is effective in preventing severe cases of COVID-19, but not as well as other two-shot variants of the vaccine that are already on the market.

Credit: ABC Action News    Duration: 01:46Published
Novavax: Fourth Covid Vaccine Could Be Approved in the UK [Video]

Novavax: Fourth Covid Vaccine Could Be Approved in the UK

A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19. The UK has secured 60 million doses of the Novavax jab, which is believed to offer protection against the new UK and South African variants. Two vaccines have already been rolled out in the UK – from Pfizer and Oxford/AstraZeneca – while a third from Moderna has been approved for use. The Novavax jab will be delivered in the second half of 2021 if it receives MHRA approval. Report by Avagninag. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:22Published
Biden admin to buy 200 million more vaccine doses [Video]

Biden admin to buy 200 million more vaccine doses

The Biden administration will purchase 200 million more coronavirus vaccines and funnel more to states now, in a bid to deliver on the president's promise to curb the pandemic. This report produced by Jillian Kitchener.

Credit: Reuters - Politics    Duration: 01:52Published

BioNTech BioNTech German biotechnology company

Pfizer’s COVID-19 Vaccine May Be Less Effective in Obese People, Study Says [Video]

Pfizer’s COVID-19 Vaccine May Be Less Effective in Obese People, Study Says

Researchers in Italy have discovered that the Pfizer/BioNTech vaccine may be less effective in obese individuals.

Credit: Cover Video STUDIO    Duration: 01:12Published
Covid vaccine reduces risk of serious illness by 80% [Video]

Covid vaccine reduces risk of serious illness by 80%

New data shows that a single jab of either the Oxford-AstraZeneca or the Pfizer-BioNTech Covid jab reduces the chance of needing hospital treatment by over 80%. Health Secretary Matt Hancock told a Downing Street press conference that "a single shot of either the Oxford/AstraZeneca vaccine or of the Pfizer vaccine works against severe infection among the over-70s with a more than 80% reduction in hospitalisations". He added that the data shows "the protection that you get from catching Covid 35 days after a first jab is even slightly better for the Oxford jab than for Pfizer, albeit both results are clearly very strong." Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 00:37Published
U.S. aims for Tuesday delivery of J&J shots [Video]

U.S. aims for Tuesday delivery of J&J shots

Initial deliveries of the newly approved Johnson & Johnson COVID-19 vaccine should start on Tuesday, senior Biden administration officials said on Sunday, saying they hoped to boost lagging vaccination rates among minorities. Bryan Wood reports.

Credit: Reuters - Politics    Duration: 01:44Published
One dose Pfizer coronavirus vaccine wards off asymptomatic transmission [Video]

One dose Pfizer coronavirus vaccine wards off asymptomatic transmission

A single dose of the Pfizer-BioNTech coronavirus vaccine reduces the risk of asymptomatic infections, helping to stem transmission, research suggests.The UK has approved three coronavirus jabs – Pfizer-BioNTech, AstraZeneca-University of Oxford and Moderna – after studies demonstrated they significantly ward off severe disease.With not everyone able to be immunised, or producing a strong immune response as a result of their vaccination, questions lingered as to whether the jabs prevented the infection itself.Asymptomatic infections are particularly important amid the pandemic, given these individuals do not know to isolate and may unwittingly transmit the coronavirus even when they speak.To learn more, medics from the Cambridge University Hospitals NHS Foundation Trust (CUH) swabbed the site's vaccinated and unvaccinated healthcare workers over two weeks.Results suggest the risk of an asymptomatic infection decreases by four times more than 12 days after a worker received the Pfizer-BioNTech jab.

Credit: Yahoo News    Duration: 00:53Published
High Number of Antibodies After Two Doses of Pfizer Vaccine [Video]

High Number of Antibodies After Two Doses of Pfizer Vaccine

New research suggests people of all ages who have had two jabs of the Pfizer-BioNTech coronavirus vaccine produce high numbers of antibodies. The Imperial College London and Ipsos Mori study, React-2, said data shows that 87.9% of people over the age of 80 tested positive for antibodies after two doses. That figure rose to 95.5% for those under 60 and 100% in those aged under 30. However, researchers warned there was not enough data to say how protected someone may be from the virus based on a positive antibody test result, and it did not mean they were immune. Report by Avagninag. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn

Credit: ODN    Duration: 01:08Published

Pfizer Pfizer American multinational pharmaceutical corporation

Pfizer and AstraZeneca vaccines 'highly effective' at preventing hospital admissions in over-80s

The Pfizer-BioNTech and Oxford-AstraZeneca coronavirus vaccines are both highly effective at preventing over-80s from being admitted to hospital, according to a..
Sky News
Biden pledges vaccine for every adult by end of May [Video]

Biden pledges vaccine for every adult by end of May

President Joe Biden on Tuesday ordered U.S. states to prioritize COVID-19 vaccinations for teachers to ensure children could return to school quickly and safely, and called for every educator to receive at least one shot by the end of March. Gloria Tso reports.

Credit: Reuters - Politics    Duration: 02:18Published
Matt Hancock: 'Exciting new data' shows effectiveness of vaccines [Video]

Matt Hancock: 'Exciting new data' shows effectiveness of vaccines

Health Secretary Matt Hancock said there was “exciting new data” showing the effectiveness of the vaccines.He told a Downing Street press conference the data showed that “a single shot of either the Oxford/AstraZeneca vaccine or of the Pfizer vaccine works against severe infection among the over-70s with a more than 80% reduction in hospitalisations”.

Credit: PA - Press Association STUDIO    Duration: 01:00Published

Related news from verified sources

US clears Moderna COVID-19 vaccine for emergency use

The United States on Friday authorised Moderna's COVID-19 vaccine for emergency use, paving the way...
Mid-Day - Published Also reported by •Zee NewsDNA


Trump jumps gun on FDA, says Moderna vaccine 'approved'

President Donald Trump said that the United States has authorized a second coronavirus vaccine,...
IndiaTimes - Published Also reported by •Zee News



Related videos from verified sources

Moderna COVID-19 Vaccine Shipped Across Country [Video]

Moderna COVID-19 Vaccine Shipped Across Country

The second vaccine was recently authorized by the FDA. This comes as million of Americans plan to travel this week for the Christmas holiday. CBS2's Nick Caloway reports.

Credit: CBS 2 New York     Duration: 02:05Published
Second COVID-19 vaccine soon available [Video]

Second COVID-19 vaccine soon available

FDA issues emergency authorization for Moderna vaccine.

Credit: FOX 4 Now Florida     Duration: 01:02Published
U.S. FDA authorizes second COVID-19 vaccine [Video]

U.S. FDA authorizes second COVID-19 vaccine

Moderna Inc's coronavirus vaccine on Friday became the second to receive emergency use authorization (EUA) from the U.S. Food and Drug Administration, welcome news to a nation with a staggering..

Credit: Reuters - Politics     Duration: 00:45Published